Lawrence Friedhoff - Concepedia

Author

Lawrence Friedhoff

Also Known As

Galante, J O, L FRIEDHOFF, L T Friedhoff, L. Friedhoff, L. T. Friedhoff, L.T Friedhoff, L.T. Friedhoff, Lawrence Friedhoff, Lawrence T Friedhoff, Lawrence T. Friedhoff

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

University of Fort Lauderdale Eisai (United States)University of Otago University of Auckland DemeRx (United States)

About

Lawrence Friedhoff is an author at University of Fort Lauderdale specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	3K
2	Health Sciences	4	4	1.7K
3	Engineering	1	1	13
4	Social Sciences	1	1	656
5	Anesthesia	1	1	22

Lawrence Friedhoff

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease Samantha Rogers, Martin R. Farlow, Rachelle S. Doody, Neurology NeuropsychologyPlacebo-controlled TrialPharmacotherapyCognitive RehabilitationGeriatric Neurology	1998	1.6K
The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial Sharon L. Rogers, Lawrence Friedhoff Dementia and Geriatric Cognitive Disorders	1996	738
DT‐01‐04: The efficacy of RVT‐101, a 5‐ht6 receptor antagonist, as an adjunct to donepezil in adults with mild‐to‐moderate Alzheimer's disease: Completer analysis of a phase 2b study Ilise Lombardo, Geetha Ramaswamy, Stephen C. Piscitelli, Alzheimer s & Dementia NeuropsychologyReceptor AntagonistNeurochemical BiomarkersPharmacotherapySocial Sciences	2015	656
The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial<sup>1</sup> Alistair Burns, Martin N. Rossor, Jane Hecker, Dementia and Geriatric Cognitive Disorders	1999	581
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study Samantha Rogers, Lawrence Friedhoff European Neuropsychopharmacology Interim AnalysisAlzheimer's DiseaseLong-term EfficacyMedicineDementia	1998	293
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities Donald C. Porter, Elena Farmaki, Serena Altilia, Proceedings of the National Academy of Sciences Conventional ChemotherapyOncologyCdk8 ExpressionMedicineCancer Biology	2012	175
Treatment with controlled-release lovastatin decreases serum concentrations of human β-amyloid (Aβ) peptide Lawrence Friedhoff, Edward I. Cullen, Neil S. Geoghagen, The International Journal of Neuropsychopharmacology	2001	98
A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia Eugene Bunnell, Melvyn Lynn, Kalim Habet, Critical Care Medicine	2000	83
Cholesterol depletion with physiological concentrations of a statin decreases the formation of the Alzheimer amyloid Aβ peptide Joseph D. Buxbaum, Neil S. Geoghagen, Lawrence Friedhoff Journal of Alzheimer s Disease	2001	73
Phenserine Efficacy in Alzheimer's Disease Bengt Winblad, Ezio Giacobini, Lutz Frölich, Journal of Alzheimer s Disease	2011	69

Page 1